Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold ...
Six products in late-stage development have the potential to launch by 2030. Credit: MargJohnsonVA via Shutterstock. · ...
It's respiratory virus season, and statewide and local numbers show the gradual rise in cases. Here is what you can do.
The viruses that scare me are the ones I don’t know about.” Anthony Fauci, long-time director of the National Institute ...
Postmortem RSV detection rate is reported as a percentage of RSV-positive cases among all-cause or respiratory deaths. To try to systematize the substantial variability in age group categories applied ...
Whooping cough cases in North Carolina have risen sharply in 2024. There have been close to 600 reported cases — 6.4 times ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunol ...
New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory ...
While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...
Adults aged 60 to 75 years old, pregnant women, and children under 2 are at the highest risk of respiratory illnesses this ...
Respiratory illness season has begun, and state and local health officials encourage everyone to protect themselves and their ...
For many of us, hopefully most of us, this is a time of vaccination. There’s the annual flu shot, of course, but also the ...